- World rank, 2022–2025
- #13,234 of 28,054 · #23,118 all time
- Rank in China
- #2,236 of 3,058
- Research works
- 219 ▲ 593% vs 2013–17
- Citations
- 2.7k 12.3 per fractional work
- Top-10% rate
- 21.0% record average 16.5%
- Open access
- 53% world 28%
Field profile
Location quotient across every field it publishes in: outside the ring is more than an institution of this size would be expected to publish, inside it is less.
Rings at 0.5×, 1× and 2×. Widest outward: Biochemistry, Genetics and Molecular Biology, 4.5×. Every wedge is a field page.
- Biochemistry, Genetics and Molecular Biology 4.5×
- Immunology and Microbiology 4.1×
- Medicine 1.8×
- Chemical Engineering 1.6×
- Pharmacology, Toxicology and Pharmaceutics 1.0×
- Computer Science 1.0×
- Agricultural and Biological Sciences 0.9×
- Business, Management and Accounting 0.9×
- Engineering 0.8×
- Decision Sciences 0.8×
- Neuroscience 0.7×
- Earth and Planetary Sciences 0.6×
- Veterinary 0.5×
- Economics, Econometrics and Finance 0.4×
- Chemistry 0.3×
- Environmental Science 0.3×
- Dentistry 0.3×
- Psychology 0.3×
- Mathematics 0.2×
- Physics and Astronomy 0.2×
- Materials Science 0.2×
- Nursing 0.1×
- Energy 0.1×
- Health Professions 0.1×
- Arts and Humanities 0.0×
- Social Sciences 0.0×
Which keywords describe research at Annoroad Gene Technology (China)?
By fractional works in 2022–2025, weighted toward what it does more of than the world: Targeted Therapy, Gene Expression, Tumor Microenvironment, Chemotherapy, Immunotherapy, Cell-Free DNA, Cancer and Genomic Instability.
- Mesenchymal Stem Cells
- Adjuvant Therapy
- Hereditary Syndromes
- RNA-Seq
- Immune Checkpoint Blockade
- Genetic Mutations
- Cancer Immunotherapy
- Lipid Peroxidation
- Prognostic Factors
- EGFR Mutations
- Precision Medicine
- Genomic Profiling
- Oxidative Stress
- Mutational Signatures
- Cancer Genomics
- Cell-Free DNA
- Machine Learning
- Tumor Microenvironment
- Gene Expression
- Deep Learning
- Targeted Therapy
- Cancer
- Epidemiology
- Chemotherapy
- Immunotherapy
- Genomic Instability
- Clinical Trials
- Neural Networks
- Molecular Characterization
- Biomarkers
- ALK Inhibitors
- Cell Death
- Ferroptosis
- Radiotherapy
- Cancer Risk
- Genetic Testing
- PD-1 and PD-L1
- Adjuvant Chemotherapy
- Microsatellite Instability
- Data Integration
Size is fractional works in 2022–2025 in the topics tagged with each word; colour is the word's share of this institution's work against its share of the world's. The 40 words are chosen for being large and distinctive. Each links to the topic it comes from most.
All 40 words, with their numbers
- Targeted Therapy7▲ 30×4 topics
- Deep Learning6▲ 1.73×32 topics
- Cancer5▲ 4.0×21 topics
- Gene Expression5▲ 8.3×12 topics
- Epidemiology5▲ 1.25×33 topics
- Tumor Microenvironment5▲ 11×5 topics
- Chemotherapy5▲ 6.6×14 topics
- Machine Learning5▲ 1.40×20 topics
- Immunotherapy5▲ 6.3×15 topics
- Cell-Free DNA4▲ 40×2 topics
- Genomic Instability4▲ 35×2 topics
- Cancer Genomics4▲ 51×1 topic
- Clinical Trials4▲ 5.4×5 topics
- Mutational Signatures4▲ 51×1 topic
- Neural Networks3▲ 2.1×12 topics
- Oxidative Stress3▲ 1.98×14 topics
- Molecular Characterization3▲ 17×5 topics
- Genomic Profiling3▲ 29×2 topics
- Biomarkers3▲ 3.9×10 topics
- Precision Medicine3▲ 5.4×6 topics
- ALK Inhibitors2▲ 39×1 topic
- EGFR Mutations2▲ 39×1 topic
- Cell Death2▲ 9.3×4 topics
- Prognostic Factors2▲ 4.8×9 topics
- Ferroptosis2▲ 26×1 topic
- Lipid Peroxidation2▲ 19×1 topic
- Radiotherapy2▲ 5.1×4 topics
- Cancer Immunotherapy2▲ 12×3 topics
- Cancer Risk2▲ 8.5×2 topics
- Genetic Mutations2▲ 4.3×12 topics
- Genetic Testing2▲ 17×2 topics
- Immune Checkpoint Blockade2▲ 17×1 topic
- PD-1 and PD-L12▲ 17×1 topic
- RNA-Seq2▲ 17×2 topics
- Adjuvant Chemotherapy2▲ 26×2 topics
- Hereditary Syndromes2▲ 56×1 topic
- Microsatellite Instability2▲ 56×1 topic
- Adjuvant Therapy2▲ 13×2 topics
- Data Integration2▲ 8.6×3 topics
- Mesenchymal Stem Cells1▲ 13×3 topics
Which research topics does Annoroad Gene Technology (China) publish most on?
By volume in 2022–2025: Cancer Genomics and Diagnostics, Lung Cancer Treatments and Mutations, Ferroptosis and cancer prognosis and Cancer Immunotherapy and Biomarkers.
Area is fractional works; colour is the subfield each topic belongs to.
- 1 Cancer Genomics and Diagnostics Cancer Research 4 works
- 2 Lung Cancer Treatments and Mutations Pulmonary and Respiratory Medicine 2 works
- 3 Ferroptosis and cancer prognosis Pulmonary and Respiratory Medicine 2 works
- 4 Cancer Immunotherapy and Biomarkers Oncology 2 works
- 5 Genetic factors in colorectal cancer Pathology and Forensic Medicine 2 works
- 6 Lung Cancer Diagnosis and Treatment Pulmonary and Respiratory Medicine 1 works
- 7 CAR-T cell therapy research Oncology 1 works
- 8 Single-cell and spatial transcriptomics Molecular Biology 1 works
- 9 E-commerce and Technology Innovations Business and International Management 1 works
- 10 Radiomics and Machine Learning in Medical Imaging Radiology, Nuclear Medicine and Imaging 1 works
How open and international is its research?
Against the world’s own shares — the tick on each track. Both are shares of its output, so they sit on one scale and can be read against each other as well as against the world.
World: 28% of research is openly available.
World: 19% is written across borders.
How has Annoroad Gene Technology (China)'s research output changed?
Output in 2018–2022 was 593% higher than in 2013–2017.
The same series as a ribbon — one cell per year, darker for more. The line above answers how much; this answers when.
Other research institutions in Beijing
- Chinese Academy of Sciences
- Tsinghua University
- Peking University
- University of Chinese Academy of Sciences
- Beihang University
- Beijing Institute of Technology
- Chinese Academy of Medical Sciences & Peking Union Medical College
- North China Electric Power University
Research measures only: rankings here say nothing about teaching, admissions or student experience. Comparable institutions and collaboration partners are in the interactive view on the map.